SE
79
-4
WEC
65
3
EL
42
3
CI
48
5
DE
60
12
PNC
67
6
TROW
40
14
LNC
40
4
AME
60
4
KEY
48
5
EQT
50
5
EFX
68
2
NI
75
5
NTRS
64
4
HBAN
70
2
EMN
42
2
PFE
33
5
AMZN
64
4
CPB
44
2
NSC
67
2
SE
79
-4
WEC
65
3
EL
42
3
CI
48
5
DE
60
12
PNC
67
6
TROW
40
14
LNC
40
4
AME
60
4
KEY
48
5
EQT
50
5
EFX
68
2
NI
75
5
NTRS
64
4
HBAN
70
2
EMN
42
2
PFE
33
5
AMZN
64
4
CPB
44
2
NSC
67
2
Financhill
Back

Nurix Therapeutics 10K Form

Buy
64

NRIX
Nurix Therapeutics

Last Price:
$12.35
Seasonality Move:
25.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NRIX News And Ratings

See the #1 stock for the next 7 days that we like better than NRIX

NRIX Financial Statistics

Sales & Book Value

Annual Sales: $54.5M
Cash Flow: $-64.6M
Price / Cash Flow: 0
Annual Sales: $6.31
Price / Book: 2.03

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-208.4M
Gross Margin: --
Return on Equity: -54.15%
Return on Assets: -39.75%

Nurix Therapeutics Earnings Forecast

Key Nurix Therapeutics Financial Ratios

  • The Research & Development expenses have been 406.30% of Revenue.
  • The Net Earning history of NRIX is -354.85% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Nurix Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NRIX
CUSIP: 67080M
Website: nurixtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.26
Quick Ratio: 6.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NRIX Technical Analysis vs Fundamental Analysis

Buy
64
Nurix Therapeutics (NRIX) is a Buy

Is Nurix Therapeutics a Buy or a Sell?